Akzo Nobel Chief Financial Officer Keith Nichols to Stand Down - - Chromatography Online
Akzo Nobel Chief Financial Officer Keith Nichols to Stand Down

LCGC Europe eNews

Akzo Nobel Chief Financial Officer Keith Nichols to Stand Down

The Supervisory Board of Akzo Nobel N.V (Amsterdam, Netherlands) has announced that Keith Nichols, Chief Financial Officer, will step down from his position at the end of June 2014.

Nichols said: "Making a decision like this is never easy but I leave the company well placed to deliver its 2015 financial targets. I would like to thank my colleagues throughout the company and wish them all the very best for the future." 

Chief Executive Officer Ton Büchner: "We thank Keith for his dedication and commitment to AkzoNobel over the past eight years. He has played a major role in the transformation of the company's portfolio, most notably in the exit of our pharmaceutical business and, since becoming CFO in 2008, has made an outstanding contribution in driving financial discipline and functional excellence across the company.” He added: “We will miss Keith's valuable and insightful input as well as his hard work and I know that I speak on behalf of all my colleagues in wishing him well for the future."

Nichols will retain his position as CFO and remain on the Board of Management until the end of June 2014. The company is currently in the process of looking for his replacement.

For more information please visit: www.akzonobel.com

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters
Global E-newsletters subscribe here:




 

LCGC COLUMNISTS 2014

Column Watch: Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments. LATEST: When Bad Things Happen to Good Food: Applications of HPLC to Detect Food Adulteration


Perspectives in Modern HPLC: Michael W. Dong is a senior scientist in Small Molecule Drug Discovery at Genentech in South San Francisco, California. He is responsible for new technologies, automation, and supporting late-stage research projects in small molecule analytical chemistry and QC of small molecule pharmaceutical sciences. LATEST: HPLC for Characterization and Quality Control of Therapeutic Monoclonal Antibodies


MS — The Practical Art: Kate Yu brings her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers. LATEST: Radical Mass Spectrometry as a New Frontier for Bioanalysis


LC Troubleshooting: LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan is able to highlight common problems and provide remedies for them. LATEST: How Much Can I Inject? Part I: Injecting in Mobile Phase


More LCGC Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>


Source: LCGC Europe eNews,
Click here